
    
      Nitazoxanide has been shown to have a clinical efficacy against severe acute respiratory
      syndrome coronavirus; ivermectin has also demonstrated a remarkable experimental efficacy
      with a potential to be used for Coronavirus disease 2019. Some studies demonstrated the
      efficacy of combined regimen of nitazoxanide and azithromycin or ivermectin and chloroquine.
    
  